Fingerprint
Dive into the research topics of 'Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically